1. Home
  2. PCVX vs KNX Comparison

PCVX vs KNX Comparison

Compare PCVX & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$56.19

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Logo Knight-Swift Transportation Holdings Inc.

KNX

Knight-Swift Transportation Holdings Inc.

N/A

Current Price

$65.45

Market Cap

11.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PCVX
KNX
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
11.7B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
PCVX
KNX
Price
$56.19
$65.45
Analyst Decision
Strong Buy
Buy
Analyst Count
11
21
Target Price
★ $109.00
$88.45
AVG Volume (30 Days)
1.2M
★ 3.1M
Earning Date
11-03-2026
10-21-2026
Dividend Yield
N/A
★ 1.26%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $7,469,689,000.00
Revenue This Year
N/A
$9.43
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.80
52 Week Low
$39.87
$40.34
52 Week High
$65.00
$82.86

Technical Indicators

Market Signals
Indicator
PCVX
KNX
Relative Strength Index (RSI) 44.39 35.81
Support Level $52.18 $58.19
Resistance Level $58.77 $68.42
Average True Range (ATR) 2.19 1.88
MACD -0.27 -0.28
Stochastic Oscillator 30.24 5.02

Price Performance

Historical Comparison
PCVX
KNX

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift Transportation is the largest full-truckload carrier in the US, with a diversified transportation offering. Roughly 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 63% and less than truckload 19%. Truck brokerage and other asset-light logistics services make up 8% of revenue, with intermodal near 5%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue is from services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: